RESULTS	Follow-up mortality ( nitroglycerin , 1.2 % ; diltiazem , 1.3 % ) , myocardial infarction ( 6 % , versus 5 % ) , and reintervention ( 8 % versus 6 % ) rates and average angina class ( 1.3 + / -0.7 versus 1.1 + / -0.4 ) were similar ( p = not significant for all ) .\